New eye drug aims to offer cheaper option for blinding disease

NCT ID NCT07614776

Recruiting now Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether a new drug called ABP 938 works as well as the approved treatment Eylea HD for wet age-related macular degeneration, a leading cause of vision loss. About 304 people aged 50 and older with untreated wet AMD will receive injections of either drug into the eye. The main goal is to see if vision improvement is similar between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ABP 938 (a biosimilar of aflibercept) and aflibercept (Eylea HD)

What this could lead to

If successful, this could provide a more affordable treatment option for wet age-related macular degeneration, helping preserve vision.

What could go wrong

This is a similarity study, not a new cure. Even if ABP 938 works as well as Eylea HD, it still requires regular eye injections and does not restore lost vision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nemaline myopathy wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NAMD NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Advanced Research, LLC
RECRUITING

Pensacola, Florida, 32503, United States
California Eye Specialists Medical Group, Inc
RECRUITING

Pasadena, California, 91107, United States
Charleston Neuroscience Institute
RECRUITING

Charleston, South Carolina, 29414-5896, United States
Medeye Associates - Research
RECRUITING

Miami, Florida, 33143, United States
Mississippi Retina Assoc
RECRUITING

Madison, Mississippi, 39110, United States
Palmetto Retina Center - Main (RCA)
RECRUITING

Columbia, South Carolina, 29169, United States
Palmetto Retina Center, Florence (RCA)
RECRUITING

West Columbia, South Carolina, 29169, United States
Retina Associates
RECRUITING

Elmhurst, Illinois, 60126, United States
Retina Consultants of Minnesota
RECRUITING

Edina, Minnesota, 55435, United States
Retina Consultants of South Carolina, Charleston Neuroscience Institute- Ladson (RCA)
RECRUITING

Ladson, South Carolina, 29456, United States
Retina Consultants of Texas - Katy Retina Center
RECRUITING

Houston, Texas, 77401, United States
Retina Consultants of Texas - Schertz
RECRUITING

Schertz, Texas, 78154, United States
Retina Specialists
RECRUITING

Towson, Maryland, 21204, United States
Retinal Consultants Medical Group, Inc - Sacramento - Parkcenter Drive (RCA)
RECRUITING

Sacramento, California, 95825, United States
South Coast Retina Center - RCA
RECRUITING

Long Beach, California, 90607, United States
Texas Retina Associates (TRA) - Arlington
RECRUITING

Arlington, Texas, 76012, United States
Texas Retina Associates (TRA) - Dallas Main
RECRUITING

Dallas, Texas, 75231, United States
Texas Retina Associates - Fort Worth
RECRUITING

Fort Worth, Texas, 76104, United States
Vision Research Center Eye Associates of New Mexico
RECRUITING

Albuquerque, New Mexico, 87109, United States
Vitreoretinal Associates of Washington
RECRUITING

Bellevue, Washington, 98004-3779, United States